Global Information
회사소개 | 문의 | 비교리스트

세계의 안구 임플란트 시장(2018-2022년)

Global Ocular Implants Market 2018-2022

리서치사 TechNavio (Infiniti Research Ltd.)
발행일 2018년 07월 상품 코드 665999
페이지 정보 영문 126 Pages
가격
US $ 2,500 ₩ 2,953,000 PDF by E-mail (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 3,000 ₩ 3,543,000 PDF by E-mail (5-user License) help
동일 사업장 내 5명까지 공유하여 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 4,000 ₩ 4,725,000 PDF by E-mail (Enterprise License) help
동일 기업 내 모든 분들이 공유하여 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 5,000 ₩ 5,906,000 PDF by E-mail (Global License) help
동일 기업 내 모든 분들이 공유하여 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다. 또한 해당 라이선스는 보고서 컨텐츠의 15% 이내로 외부용 문서에 인용 게재가 허용됩니다(예:프레스릴리스, 마케팅 자료, 백서 등).


세계의 안구 임플란트 시장(2018-2022년) Global Ocular Implants Market 2018-2022
발행일 : 2018년 07월 페이지 정보 : 영문 126 Pages

안구 임플란트에 대해

안구 임플란트는 손상된 시각기관 또는 결손된 시각기관을 교환해 시력을 회복시키기거나 외관을 개선하도록 설계된 의료기기입니다. 의안 같은 안구 임플란트는 눈의 질환 또는 외상에 의한 얼굴 윤곽의 손상을 개선하기 위해 사용하는 인공 눈입니다.

Technavio의 애널리스트는 2018-2022년간 세계의 안구 임플란트 시장이 12.52%의 연평균 성장률(CAGR)로 성장할 것으로 예측했습니다.

세계의 안구 임플란트(Ocular Implants) 시장에 대해 조사 분석했으며, 시장 규모와 성장률, 시장 동향, 시장 성장 촉진요인과 과제, 시장 기회, 주요 벤더 등의 정보를 전해드립니다.

목차

제1장 주요 요약

제2장 조사 범위

제3장 조사 방법

제4장 시장 상황

  • 시장 생태계
  • 시장 특성
  • 시장 세분화 분석

제5장 시장 규모

  • 시장 정의
  • 시장 규모(2017년)
  • 시장 규모 및 예측(2017-2022년)

제6장 Five Forces 분석

  • 구매자의 협상력
  • 공급업체의 협상력
  • 신규 참여업체의 위협
  • 대체품의 위협
  • 경쟁사의 위협
  • 시장 상황

제7장 시장 세분화 : 제품별

  • 세분화 : 제품별
  • 비교 : 제품별
  • IOL
  • 녹내장 임플란트
  • 각막 임플란트
  • 의안
  • 시장 기회 : 제품별

제8장 고객 상황

제9장 지역 상황

  • 지역별 세분화(2017-2022년)
  • 지역 비교
  • 아메리카
  • 유럽, 중동 및 아프리카
  • 아시아태평양
  • 시장 기회

제10장 의사결정 체계

제11장 성장요인과 과제

  • 시장 성장요인
  • 시장 과제

제12장 시장 동향

  • 맞춤형 의안
  • 안과 시술용 병원에 대한 ASC의 선호 증가
  • 백내장 수술용 의료 관광의 증가

제13장 벤더 상황

  • 개요
  • 창조적 파괴 상황

제14장 벤더 분석

  • 대상 벤더
  • 벤더 분류
  • 벤더의 시장 포지셔닝
  • Carl Zeiss Meditec
  • Johnson & Johnson
  • MORCHER
  • NIDEK
  • Novartis
  • Valeant Pharmaceuticals

제15장 부록

  • 약어 리스트
KSM 18.08.03

About Ocular Implants

Ocular implants are medical devices designed to replace a damaged or missing visual organ to restore vision or to improve visual appearance. Ocular implants such as ocular prostheses are artificial eyes used by people to improve facial lineaments damages due to an eye disease or trauma.

Technavio's analysts forecast the global ocular implants market to grow at a CAGR of 12.52% during the period 2018-2022.

Covered in this report

The report covers the present scenario and the growth prospects of the global ocular implants market for 2018-2022. To calculate the market size, the report considers the revenue generated from the sales of IOLs, corneal implants, glaucoma implants, and ocular prostheses.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Ocular Implants Market 2018-2022, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Carl Zeiss Meditec
  • Johnson & Johnson
  • MORCHER
  • NIDEK
  • Novartis
  • Valeant Pharmaceuticals

Market driver

  • Increasing access to ocular implants in emerging markets
  • For a full, detailed list, view our report

Market challenge

  • Limited reimbursements for ocular implants
  • For a full, detailed list, view our report

Market trend

  • Increasing medical tourism for cataract surgery
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2022 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

PART 03: RESEARCH METHODOLOGY

PART 04: MARKET LANDSCAPE

  • Market ecosystem
  • Market characteristics
  • Market segmentation analysis

PART 05: MARKET SIZING

  • Market definition
  • Market sizing 2017
  • Market size and forecast 2017-2022

PART 06: FIVE FORCES ANALYSIS

  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

PART 07: MARKET SEGMENTATION BY PRODUCT

  • Segmentation by product
  • Comparison by product
  • IOLs
  • Glaucoma implants
  • Corneal implants
  • Ocular prostheses
  • Market opportunity by product

PART 08: CUSTOMER LANDSCAPE

PART 09: REGIONAL LANDSCAPE

  • Geographical segmentation
  • Regional comparison
  • Americas - Market size and forecast 2017-2022
  • EMEA - Market size and forecast 2017-2022
  • APAC - Market size and forecast 2017-2022
  • Market opportunity

PART 10: DECISION FRAMEWORK

PART 11: DRIVERS AND CHALLENGES

  • Market drivers
  • Market challenges

PART 12: MARKET TRENDS

  • Custom-made ocular prostheses
  • Increasing preference for ASCs over hospitals for ophthalmology procedures
  • Increasing medical tourism for cataract surgery

PART 13: VENDOR LANDSCAPE

  • Overview
  • Landscape disruption

PART 14: VENDOR ANALYSIS

  • Vendors covered
  • Vendor classification
  • Market positioning of vendors
  • Carl Zeiss Meditec
  • Johnson & Johnson
  • MORCHER
  • NIDEK
  • Novartis
  • Valeant Pharmaceuticals

PART 15: APPENDIX

  • List of abbreviations

List of Exhibits

  • Exhibit 01: Global ophthalmology devices market
  • Exhibit 02: Global ophthalmology devices market - Segmentation
  • Exhibit 03: Market characteristics
  • Exhibit 04: Market segments
  • Exhibit 05: Market definition - Inclusions and exclusions checklist
  • Exhibit 06: Market size 2017
  • Exhibit 07: Validation techniques employed for market sizing 2017
  • Exhibit 08: Global ocular implants market - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 09: Global ocular implants market - Year-over-year growth 2018-2022 (%)
  • Exhibit 10: Five forces analysis 2017
  • Exhibit 11: Five forces analysis 2022
  • Exhibit 12: Bargaining power of buyers
  • Exhibit 13: Bargaining power of suppliers
  • Exhibit 14: Threat of new entrants
  • Exhibit 15: Threat of substitutes
  • Exhibit 16: Threat of rivalry
  • Exhibit 17: Market condition - Five forces 2017
  • Exhibit 18: Global ocular implants market by product - Market share 2017-2022 (%)
  • Exhibit 19: Comparison by product
  • Exhibit 20: Global IOLs market - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 21: Global IOLs market - Year-over-year growth 2018-2022 (%)
  • Exhibit 22: Global glaucoma implants market - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 23: Global glaucoma implants market - Year-over-year growth 2018-2022 (%)
  • Exhibit 24: Global corneal implants market - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 25: Global corneal implants market - Year-over-year growth 2018-2022 (%)
  • Exhibit 26: Global ocular prostheses market - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 27: Global ocular prostheses market - Year-over-year growth 2018-2022 (%)
  • Exhibit 28: Market opportunity by product
  • Exhibit 29: Customer landscape
  • Exhibit 30: Global ocular implants market share by geography 2017-2022 (%)
  • Exhibit 31: Global ocular implants market - Regional comparison
  • Exhibit 32: Americas - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 33: Americas - Year-over-year growth 2018-2022 (%)
  • Exhibit 34: Top 3 countries in Americas
  • Exhibit 35: EMEA - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 36: EMEA - Year-over-year growth 2018-2022 (%)
  • Exhibit 37: Top 3 countries in EMEA
  • Exhibit 38: APAC - Market size and forecast 2017-2022 ($ mn)
  • Exhibit 39: APAC - Year-over-year growth 2018-2022 (%)
  • Exhibit 40: Top 3 countries in APAC
  • Exhibit 41: Market opportunity
  • Exhibit 42: Vendor landscape
  • Exhibit 43: Landscape disruption
  • Exhibit 44: Vendors covered
  • Exhibit 45: Vendor classification
  • Exhibit 46: Market positioning of vendors
  • Exhibit 47: Carl Zeiss Meditec - Overview
  • Exhibit 48: Carl Zeiss Meditec - Business segments
  • Exhibit 49: Carl Zeiss Meditec - Organizational developments
  • Exhibit 50: Carl Zeiss Meditec - Geographic focus
  • Exhibit 51: Carl Zeiss Meditec - Segment focus
  • Exhibit 52: Carl Zeiss Meditec - Key offerings
  • Exhibit 53: Carl Zeiss Meditec - Key customers
  • Exhibit 54: Johnson & Johnson - Overview
  • Exhibit 55: Johnson & Johnson - Business segments
  • Exhibit 56: Johnson & Johnson - Organizational developments
  • Exhibit 57: Johnson & Johnson - Geographic focus
  • Exhibit 58: Johnson & Johnson - Segment focus
  • Exhibit 59: Johnson & Johnson - Key offerings
  • Exhibit 60: Johnson & Johnson - Key customers
  • Exhibit 61: MORCHER - Overview
  • Exhibit 62: MORCHER - Product segments
  • Exhibit 63: MORCHER - Organizational developments
  • Exhibit 64: MORCHER - Geographic focus
  • Exhibit 65: MORCHER - Product segment focus
  • Exhibit 66: MORCHER - Key offerings
  • Exhibit 67: MORCHER - Key customers
  • Exhibit 68: NIDEK - Overview
  • Exhibit 69: NIDEK - Product segments
  • Exhibit 70: NIDEK - Organizational developments
  • Exhibit 71: NIDEK - Geographic focus
  • Exhibit 72: NIDEK - Product segment focus
  • Exhibit 73: NIDEK - Key offerings
  • Exhibit 74: NIDEK - Key customers
  • Exhibit 75: Novartis - Overview
  • Exhibit 76: Novartis - Business segments
  • Exhibit 77: Novartis - Organizational developments
  • Exhibit 78: Novartis - Geographic focus
  • Exhibit 79: Novartis - Segment focus
  • Exhibit 80: Novartis - Key offerings
  • Exhibit 81: Novartis - Key customers
  • Exhibit 82: Valeant Pharmaceuticals - Overview
  • Exhibit 83: Valeant Pharmaceuticals - Business segments
  • Exhibit 84: Valeant Pharmaceuticals - Organizational developments
  • Exhibit 85: Valeant Pharmaceuticals - Geographic focus
  • Exhibit 86: Valeant Pharmaceuticals - Segment focus
  • Exhibit 87: Valeant - Key offerings
  • Exhibit 88: Valeant Pharmaceuticals - Key customers
Back to Top
전화 문의
F A Q